These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16333243)

  • 1. Management of febrile neutropenia in the United Kingdom: time for a national trial?
    Innes H; Billingham L; Gaunt C; Steven N; Marshall E
    Br J Cancer; 2005 Dec; 93(12):1324-8. PubMed ID: 16333243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.
    Haeusler GM; Slavin MA; Bryant PA; Babl FE; Mechinaud F; Thursky KA
    J Paediatr Child Health; 2018 Jul; 54(7):761-769. PubMed ID: 29655245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current clinical practice in the treatment of febrile neutropenia (FN)].
    Takei N; Komatsu T
    Jpn J Antibiot; 2011 Oct; 64(5):293-310. PubMed ID: 22428213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of the antibiotic treatment of febrile neutropenia in haematology units in the United Kingdom.
    Ziglam HM; Gelly KJ; Olver WJ
    Clin Lab Haematol; 2005 Dec; 27(6):374-8. PubMed ID: 16307538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA.
    Freifeld A; Sankaranarayanan J; Ullrich F; Sun J
    Support Care Cancer; 2008 Feb; 16(2):181-91. PubMed ID: 17943327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis.
    Teuffel O; Ethier MC; Alibhai SMH; Beyene J; Sung L
    Ann Oncol; 2011 Nov; 22(11):2358-2365. PubMed ID: 21363878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre.
    Schelenz S; Giles D; Abdallah S
    Ann Oncol; 2012 Jul; 23(7):1889-93. PubMed ID: 22048152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
    Hodgson-Viden H; Grundy PE; Robinson JL
    BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.
    Teuffel O; Cheng S; Ethier MC; Diorio C; Martino J; Mayo C; Wing R; Sung L; Alibhai SM
    Support Care Cancer; 2012 Nov; 20(11):2755-64. PubMed ID: 22350594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.
    Manji A; Beyene J; Dupuis LL; Phillips R; Lehrnbecher T; Sung L
    Support Care Cancer; 2012 Jun; 20(6):1135-45. PubMed ID: 22402749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres.
    Phillips B; Selwood K; Lane SM; Skinner R; Gibson F; Chisholm JC;
    Arch Dis Child; 2007 Jun; 92(6):495-8. PubMed ID: 17284481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia in French emergency departments: results of a prospective multicentre survey.
    André S; Taboulet P; Elie C; Milpied N; Nahon M; Kierzek G; Billemont M; Perruche F; Charpentier S; Clément H; Pourriat JL; Claessens YE
    Crit Care; 2010; 14(2):R68. PubMed ID: 20403164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group.
    Parsons SK; Mayer DK; Alexander SW; Xu R; Land V; Laver J
    J Pediatr Hematol Oncol; 2000; 22(3):227-41. PubMed ID: 10864054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
    Escalante CP; Rubenstein EB; Rolston KV
    Support Care Cancer; 1996 Sep; 4(5):358-63. PubMed ID: 8883229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?
    Karthaus M; Carratalà J; Jürgens H; Ganser A
    Chemotherapy; 1998; 44(6):427-35. PubMed ID: 9755304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.